Anyone else frustrated with the SP with all the positive news we have received lately?, page-45

How do you put a value on a company with so many pipelines and potential partners at its disposal. I agree that the Viralytics theme is a carbon copy with regards to Merck and how the SP is playing out with so many good announcements but the difference is , Viralytics was basically a one trick pony and it got bought out as one so to speak . Where do you start with Imugene if you want to perform a t/o with so many entities at play ?
My instincts tell me that Imugene will partner in some way with a few of the players with Imugene controlling which pipelines go where and ultimately receive royalties from all their products till 2036 . Now , what would imugene be worth then ? I'd say we would be thought of as Big Pharma if these predictions of mine were realised